Response

Affiliations

¹ Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, National Clinical Research Center for Respiratory Diseases, China-Japan Friendship Hospital, Beijing, China; Department of Respiratory Medicine, Capital Medical University, Beijing, China; Institute of Respiratory Medicine, Chinese Academy of Medical Science, Beijing, China.
² Tsinghua University School of Medicine, Beijing, China.
³ Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, National Clinical Research Center for Respiratory Diseases, China-Japan Friendship Hospital, Beijing, China; Department of Respiratory Medicine, Capital Medical University, Beijing, China; Institute of Respiratory Medicine, Chinese Academy of Medical Science, Beijing, China; Tsinghua University-Peking University Joint Center for Life Sciences, Beijing, China. Electronic address: caobin_ben@163.com.

Comment

Hui Li et al. Chest. 2021 Jul.

. 2021 Jul;160(1):e86.

doi: 10.1016/j.chest.2021.02.075.

¹ Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, National Clinical Research Center for Respiratory Diseases, China-Japan Friendship Hospital, Beijing, China; Department of Respiratory Medicine, Capital Medical University, Beijing, China; Institute of Respiratory Medicine, Chinese Academy of Medical Science, Beijing, China.
² Tsinghua University School of Medicine, Beijing, China.
³ Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, National Clinical Research Center for Respiratory Diseases, China-Japan Friendship Hospital, Beijing, China; Department of Respiratory Medicine, Capital Medical University, Beijing, China; Institute of Respiratory Medicine, Chinese Academy of Medical Science, Beijing, China; Tsinghua University-Peking University Joint Center for Life Sciences, Beijing, China. Electronic address: caobin_ben@163.com.

No abstract available

Comment on

Risk Factors of Viral RNAaemia and Its Association With Clinical Prognosis Among Patients With Severe COVID-19.
Li H, Gu X, Li H, Gong F, Xu J, Wang Y, Li H, Ruan S, Yang Q, Cao B. Li H, et al. Chest. 2021 Apr;159(4):1382-1386. doi: 10.1016/j.chest.2020.11.071. Epub 2021 Jan 6. Chest. 2021. PMID: 33421381 Free PMC article. No abstract available.
A Study Revealed That a High Percentage of Patients With Severe COVID-19 With Viral RNAaemia Had Significantly Worse Outcomes, and This Is the First Report About the Risk Factors of Viral RNAaemia in Patients With COVID-19: We Are Not Sure!
Honore PM, Redant S, Preseau T, Kaefer K, Barreto Gutierrez L, Attou R, Gallerani A, De Bels D. Honore PM, et al. Chest. 2021 Jul;160(1):e85-e86. doi: 10.1016/j.chest.2021.02.074. Chest. 2021. PMID: 34246395 Free PMC article. No abstract available.

1. Huang C., Wang Y., Li X., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. - PMC - PubMed
1. Li H., Gu X., Xu J., et al. Risk factors of viral RNAaemia and its association with clinical prognosis among patients with severe coronavirus disease 2019. Chest. 2021;159(4):1382–1386. - PMC - PubMed
1. Fajnzylber J., Regan J., Coxen K., et al. SARS-CoV-2 viral load is associated with increased disease severity and mortality. Nat Commun. 2020;11(1):5493. - PMC - PubMed
1. Monteil V., Kwon H., Prado P., et al. Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2. Cell. 2020;181(4):905–913. - PMC - PubMed
1. Gniazdowski V., Morris C.P., Wohl S., et al. Repeat COVID-19 molecular testing: correlation of SARS-CoV-2 culture with molecular assays and cycle thresholds [Published online ahead of print October 27, 2020] Clin Infect Dis. 2020 doi: 10.1093/cid/ciaa1616. - DOI